ArticleNature communications2021

Agonistic CD40 therapy induces tertiary lymphoid structures but impairs responses to checkpoint blockade in glioma.

Luuk van Hooren et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.